Angelman syndrome

15,330views

Angelman syndrome

12345

12345

Introduction to the skeletal system
Introduction to the cardiovascular system
Introduction to the muscular system
Anatomical terminology
Anatomy of the muscles and nerves of the posterior abdominal wall
Anatomy of the abdominal viscera: Innervation of the abdominal viscera
Enteric nervous system
Physiological changes during exercise
Pentose phosphate pathway
Glycolysis
Electron transport chain and oxidative phosphorylation
Development of the face and palate
Pharyngeal arches, pouches, and clefts
Development of the teeth
Development of the tongue
Citric acid cycle
Gluconeogenesis
Nitrogen and urea cycle
Amino acid metabolism
Fatty acid synthesis
Ketone body metabolism
Fatty acid oxidation
Cholesterol metabolism
Glucose-6-phosphate dehydrogenase (G6PD) deficiency
Glycogen storage disease type III
Glycogen storage disease type IV
Glycogen storage disease type V
Gaucher disease (NORD)
Cystinosis
Ornithine transcarbamylase deficiency
Familial hypercholesterolemia
Disorders of carbohydrate metabolism: Pathology review
Dyslipidemias: Pathology review
Glycogen storage disorders: Pathology review
Disorders of fatty acid metabolism: Pathology review
Lysosomal storage disorders: Pathology review
Disorders of amino acid metabolism: Pathology review
Carbohydrates and sugars
Proteins
Fats and lipids
Vitamin B12 deficiency
Fat-soluble vitamin deficiency and toxicity: Pathology review
Water-soluble vitamin deficiency and toxicity: B1-B7: Pathology review
Zinc deficiency and protein-energy malnutrition: Pathology review
Nernst equation
Nernst equation
Peroxisomal disorders: Pathology review
Peroxisomal disorders: Pathology review
Nuclear structure
Nuclear structure
Amino acids and protein folding
Amino acids and protein folding
Nucleotide metabolism
Nucleotide metabolism
Mitosis and meiosis
Mitosis and meiosis
Adenosine deaminase deficiency
Adenosine deaminase deficiency
Purine and pyrimidine synthesis and metabolism disorders: Pathology review
Purine and pyrimidine synthesis and metabolism disorders: Pathology review
Polymerase chain reaction (PCR) and reverse-transcriptase PCR (RT-PCR)
Polymerase chain reaction (PCR) and reverse-transcriptase PCR (RT-PCR)
ELISA (Enzyme-linked immunosorbent assay)
DNA cloning
Fluorescence in situ hybridization
Gel electrophoresis and genetic testing
Lactose intolerance
Down syndrome (Trisomy 21)
Edwards syndrome (Trisomy 18)
Patau syndrome (Trisomy 13)
Huntington disease
Fragile X syndrome
Myotonic dystrophy
Friedreich ataxia
Prader-Willi syndrome
Angelman syndrome
Polycystic kidney disease
Familial adenomatous polyposis
Alpha-thalassemia
Beta-thalassemia
Miscellaneous genetic disorders: Pathology review
Muscular dystrophies and mitochondrial myopathies: Pathology review
Autosomal trisomies: Pathology review
Mitochondrial myopathy
Gestational diabetes
Placental abruption
Preeclampsia & eclampsia
Fetal alcohol syndrome
Testicular tumors: Pathology review
Disorders of sex chromosomes: Pathology review
Prostate disorders and cancer: Pathology review
Uterine disorders: Pathology review
Cervical cancer: Pathology review
Ovarian cysts and tumors: Pathology review
Vaginal and vulvar disorders: Pathology review
Breast cancer: Pathology review
Congenital TORCH infections: Pathology review
Disorders of sexual development and sex hormones: Pathology review
Complications during pregnancy: Pathology review
Amenorrhea: Pathology review
Adrenergic antagonists: Alpha blockers
Androgens and antiandrogens
PDE5 inhibitors
Aromatase inhibitors
Uterine stimulants and relaxants
Estrogens and antiestrogens
Progestins and antiprogestins

Transcript

Watch video only

Content Reviewers

Angelman syndrome is a genetic disorder that causes intellectual and developmental delay, seizures, frequent laughter, and ataxia, or poor control of voluntary movements.

Now, it happens when a gene on chromosome 15 called UBE3A is not expressed, or transcribed into messenger RNA.

UBE3A stands for ubiquitin-protein ligase E3A, and the protein it codes for is called E6AP or E6-associated protein.

The job of E6AP is to go around tagging, or attaching, a tiny protein called ubiquitin to other proteins, a process called ubiquitination.

Once that happens, the ubiquitinated protein is degraded by the proteasome, a part of the cell’s recycling machinery.

It’s kind of painting an orange U on a tree so that a lumberjack knows to chop it down.

So E6 associated protein has an important job, and it turns out that the region of chromosome 15 around UBE3A is imprinted, imprinting refers to gene expression that’s dependent on the parent of origin of a gene.

This means that either the maternally derived or paternally derived copy of the gene is silenced.

This differs from most genes in the genome, where both the maternal and paternal copies are expressed.

Normally, in the brain, only the maternally derived copy of UBE3A is expressed, while the paternal copy is silenced, unfortunately this process of imprinting leaves the maternal copy of UBE3A vulnerable.

So with the paternal copy of the gene imprinted, and epigenetically silenced, you’ve only got the maternal copy left.

So this means that if anything happens to the maternal copy, the result is Angelman syndrome.

There are a few different types of mutations that can cause Angelman syndrome.

The most common one is a deletion of a couple million base pairs of DNA on the maternal copy of chromosome 15 which includes UBE3A.

Sometimes the deletion overlaps a nearby gene called OCA2, which codes for a pigment that gives color to eye, hair, and skin.

As a result of this, these Angelman syndrome patients can have a light complexion.

A second way is a mutation within the maternal copy of UBE3A, making the protein ineffective.

A third way to get Angelman syndrome is when the entire maternal chromosome 15 is absent and instead there’s an extra copy of the paternal chromosome 15.

This scenario is called paternal uniparental disomy, which means that one parent – the father – contributed two of the same chromosome while the mother contributed none.

Key Takeaways

Angelman syndrome (AS) is a genetic neurodevelopmental disorder characterized by problems with motor skills, speech, developmental delay, and learning disabilities. People with AS typically have happy dispositions and frequently laugh or smile, even when they are not engaged in activities that would typically elicit such reactions.

Most individuals with AS do not develop fluent speech, have sleep disturbance, and usually have seizures. People with AS typically have a normal life expectancy and have the potential to improve on some self-help skills with proper supportive care.